Antitumor effect of monoclonal antibody-carboplatin conjugates in nude mice bearing human ovarian cancer cells

[1]  E. Otsuji,et al.  Production, Binding and Cytotoxicity of Human/Mouse Chimeric Monoclonal Antibody‐Neocarzinostatin Conjugate , 1993, Japanese journal of cancer research : Gann.

[2]  H. Sakahara,et al.  Clinical immunoscintigraphy of ovarian carcinoma using iodine-131-labeled 145-9 monoclonal antibody. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[3]  浩三 今井,et al.  モノクローナル抗体-抗癌剤(アドリアマイシン)結合体による癌治療の基礎的検討 , 1993 .

[4]  M. Wilchek,et al.  Indirect immunotargeting of CIS‐PT to human epidermoid carcinoma KB using the avidin‐biotin system , 1991, International journal of cancer.

[5]  M. Wilchek,et al.  Cis-platinum (II) complexes of carboxymethyl-dextran as potential antitumor agents. II. In vitro and in vivo activity. , 1986, Cancer biochemistry biophysics.

[6]  M. Sela,et al.  Chemotherapy by intravenous administration of conjugates of daunomycin with monoclonal and conventional anti-rat alpha-fetoprotein antibodies. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[7]  C. Milstein,et al.  Continuous cultures of fused cells secreting antibody of predefined specificity , 1975, Nature.

[8]  M. Sela,et al.  The specific cytotoxic effects of daunomycin conjugated to antitumor antibodies. , 1975, Cancer research.

[9]  H. Arnberg,et al.  Immunotargeting with monoclonal cytokeratin 8 antibodies of human urothelial cancer transplanted to nude mice. , 1993, Acta oncologica.

[10]  P. Ehrlich,et al.  Croonian lecture.—On immunity with special reference to cell life , 1900, Proceedings of the Royal Society of London.